Among those, liquid biopsy sensors exploiting aptamers for the detection of cancer biomarkers in body fluids are useful and accurate tools for a fast and inexpensive non-invasive screening of population. The incorporation of aptamers in electrochemical sandwich biosensors using enzyme labels, a so-...
Cancer diagnosis and risk stratification tests are routinely performed using biopsy or cytology material obtained from primary tumors1,2. These methods present limitations that could be overcome by implementing liquid biopsy from body fluids instead. Indeed, biopsy has the inconvenience of being invasive ...
Lung cancer remains the leading cause of cancer deaths worldwide. Although low-dose spiral computed tomography (LDCT) screening is used for the detection of lung cancer in a high-risk population, false-positive results of LDCT remain a clinical problem.
NIH researchers develop AI tool for personalized oncology By: Veronica Salib Exploring 3 common types of viral hepatitis: hepatitis A, B, C By: Veronica Salib Machine Learning, ‘Liquid Biopsy’ to Bolster Early Cancer Detection By: Shania Kennedy Machine Learning Model Predicts Individ...
Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy Research (Washington, D.C.), 2021 (2021), Article 9862876 View in ScopusGoogle Scholar [51] J. Chen, Y. Xu, Y. Lu, et al. Isolation and Visible Detection of Tumor-Derived Exosomes from Plasma Anal Che...
To confirm a cancer diagnosis, an invasive procedure such as a biopsy must be undertaken which can cause side effects in the patient. To remove the need for an invasive procedure, a team of researchers from Spain and Ireland analysed the differences in PSA glycosylation be...
In addition to the data being presented at ASCO 2023, Merck will launch a new educational initiative for oncology professionals on the unmet medical need in LA SCCHN, cancer’s resistance to apoptosis, and the role of apoptosis proteins. More information on the initiative can be found atwww.Th...
MORE ON THIS TOPIC Cancer AstraZeneca/Daiichi Sankyo, BioNTech, Merus to Present Promising Cancer Therapies at ESMO Asia 2024 December 2, 2024 · 4 min read · Tristan Manalac MASH Novo, Viking Heat Up MAS...
diagnostic tests for urological cancers, MDxHealth supplemented its prostate cancer test, ConfirmMDx, with a urine-based "liquid-biopsy" test called SelectMDx. These two solutions can significantly reduce the number of unnecessary biopsy procedures thereby eliminating needless pain, infection, and cost....
Since it is well known that tumoral cell survival depend on angiogenesis, we propose that, in some tumors, HIF-3α expression is essential for cancer cell proliferation. Accordingly, downmodulation of HIF-3α could be used to prevent and/or treat these tumors. Therefore, the invention ...